SUMMARY We report five children who presented with Raynaud's disease in whom we could find no clinical, haematological, or immunological evidence of a collagen disorder. Oral phenoxybenzamine proved useful for maintenance treatment in most, with infusions of prostacyclin, nitroprusside, and ketanserin during acute attacks.
Raynaud's syndrome indicates reversible, intermittent pallor or cyanosis, or both, of the fingers or toes in response to cold or stress, and is rare in childhood. In severe cases the ischaemia may lead to areas of infarction in the hands and feet. According to current nomenclature, the term Raynaud's disease describes idiopathic Raynaud's syndrome whereas the term Raynaud's phenomenon indicates that the condition is secondary to another disease. In childhood, Raynaud's phenomenon is generally associated with a collegen disorder and is more common than the idiopathic disease. 1 The first description of Raynaud's disease in children was published in 1967,2 although earlier adult series included patients whose symptoms began in childhood,3 4and there have been a limited number of reports since.
In adults with apparent Raynaud's disease, certain haematological and immunological parameters have been shown to be associated with the development of a collagen disorder,8 and a variety of drugs have recently been used with effect;9 but there remains little information about the prognosis and treatment in children. We describe five children with Raynaud's disease and discuss their investigations, treatment, and progress.
Methods
Platelet aggregation titres were determined using a method adapted from that of Penttinen and Myllyla. In January 1980 a 7 year old girl presented with a two year history of winter chilblains affecting her right foot predominantly and a month's history of cold right toes with the development of areas of necrosis on the tips of the first two. She is of Asian origin and was born in this country after an uneventful pregnancy, and a delivery at term by caesarean section because of breech presentation. Her birthweight was 2-34 kg. There was nothing of importance in her past or family medical history. She was short with a height and weight below the 3rd centile. She had normal peripheral pulses but some limb asymmetry, her right arm being larger than her left and her left leg longer than her right by 4*0 cms. She had a single cafe au lait spot. Her skeletal survey showed various spinal anomalies including spinal dysraphism of the sixth and seventh cervical vertebrae and partial fusion of these vertebrae on the right. Raynaud' s syndrome during the previous two months, she had also developed patches of necrosis on the tips of her first four right toes but she was otherwise healthy and there was nothing of importance in her birth or past medical history. Her father is Asian and her mother Caucasian. Examination showed no abnormality apart from her cool hands and feet and toe ulcers. Thermography showed changes typical of Raynaud's syndrome.
Patient 5
In October 1983, a 5 year old Caucasian boy presented with a 10 day history of pain and blueness of his fingers and of necrosis of his right fourth and left second and fourth finger tips. There was no known history of cold exposure. There was nothing of importance in his birth, past, or family medical history except that a number of father's relatives had suffered from lymphomas. On examination his hands were noted to be cool, he had small necrotic lesions on his finger tips and his pulses were normal; no other abnormality was noted. Thermography showed normal pressures in the palmar arches but a gradual fall off along the digital vessels; cold stress initiated vasospasm and the limb vasculature was normal.
Investigations. All patients had normal haematological indices on hospital admission and at follow up. Their indirect Coombs' tests, cold agglutinins, cryoglobulins, plasma fibrinogen, and plasma viscosity were estimated on admission and were normal apart from three who had slightly low plasma viscosity values (patient 2, 1-09 cp; patient 3, 1-22 cp; patient 4, 1-3 cp; normal range 1.5 to 1.75 cp) and two whose plasma fibrinogen concentrations were low (patient 2, 1-8 g/l; patient 3, 1-2 g/l; normal range 2 to 4 g/l). No patient had an abnormality of immunoglobulins and all had negative rheumatoid factors, antinuclear factors, and autoantibody screens. All children had normal C3 values but four had slightly raised values of C4 (patient 2, 94 mg/100 ml; patient 3, 152 mg/100 ml; patient 4, 94 mg/10 ml; and patient 5, 92 mg/100 ml: normal range 20 to 65 mg/100 ml). Four patients had raised platelet aggregation titres. In three (patients 2, 3, and 4, x 3 log2 control) this test was performed while they were asymptomatic and was mildly abnormal. In the fourth (patient 1, x 6 log2 control) it was raised during an acute attack, but when she was asymptomatic it was normal. In only one patient (patient 1) was spontaneous platelet aggregation noted and this was during an acute attack.
Treatment and progress. Details of the various drugs used in the treatment of these children are given in the Table. Three of the children (patients 2, 3, and 4) responded to oral phenoxybenzamine. Their necrotic lesions slowly healed and they became asymptomatic. They have remained on treatment for 29, 25, and 18 months respectively, and are well.
The first patient (patient 1) also responded to oral phenoxybenzamine initially, and her hands and feet became warmer and her toe lesions healed. She remained on phenoxybenzamine for three years until she went to India on holiday and the drug was Oral phenoxybenzamine was not effective in the acute management of the last patient (patient 5). Infusions of prostacyclin and nitroprusside produced transient clinical improvement, but a sustained response was only obtained with a combination of iv followed by oral ketanserin and oral nifedipine. Once the lesions had begun to heal he was started on transdermal prostaglandin analogue (CL115,347,Cyanamid-kindly provided by Dr E D Cook). Over the subsequent six months he was weaned off the oral medications and is now maintained on the prostaglandin analogue. Ten months after diagnosis, he remains well.
Discussion
These children all presented with Raynaud's syndrome of sufficient severity to cause ischaemic changes to their fingers or toes. In four the symptoms were precipitated by cold and in the fifth, the boy who was too young to give details of the history himself (patient 5), this also seemed likely. In retrospect, stress may have been a contributory precipitating factor in the child who later suffered a non-accidental injury (patient 3). Four of our patients are of Asian origin and developed symptoms of Raynaud's syndrome only while they were in the UK. We are not aware of any increased incidence of Raynaud's disease on the Indian subcontinent or among the Asian population of this country. Simple enquiries did not disclose that any ergot-containing medicines or foods had been used by the families of these children. Certain features of patient 1 suggest a diagnosis of neurofibromatosis. Involvement of the heart and aorta, renal, carotid, and other arteries may occur in that condition'3 and Erickson et al described two sisters with neurofibromatosis and intracranial arterial occlusive disease. 14 We, however, were unable to show any large vessel disease in our patient and as far as we are aware, neurofibromatosis has not been previously reported in association with Raynaud's syndrome.
Raynaud's syndrome is a well recognised presenting feature of collagen disorders in childhood, particularly mixed connective tissue disease, but it is generally not an isolated symptom and serological evidence of the underlying disorder is usually found. From adult studies it seems unlikely that a patient with isolated Raynaud's syndrome will develop a c6llagenosis if there is no suggestion of this within 12 months of presentation.15 All but one of our patients have been followed up for longer than a year, none have developed clinical evidence of a collagen disorder, and their immunological studies remain normal, apart from four with high normal serum C4 value.
The presence of circulating immune complexes, spontaneous platelet aggregation, and fibrinolytic activity have been shown to correlate well with Raynaud's phenomenon secondary to a collagen disease in adults.8 Spontaneous platelet aggregation was observed in one of our patients (patient 1). She also had a raised platelet aggregation titre during an acute attack, although not subsequently. Three other children had slightly raised platelet aggregation titres, two had slightly low plasma fibrinogen concentrations, and three low plasma viscosity values. The latter observations contrast with the hyperfibrinogenaemia and raised viscosity values that have been reported in adults with Raynaud's phenomenon. The importance of the findings in the absence of evidence of a collagen disorder is unclear. It seems appropriate for our patients to be diagnosed as having Raynaud Vasodilators, either acting via the sympathetic nervous system as a-adrenergic blockers or by directly relaxing smooth muscle, have proved useful in many patients with Raynaud's syndrome. Oral phenoxybenzamine was beneficial in four of our patients but in the acute stage of the illness did not appreciably help the two with the worst disease (patients 1 and 5). Both children were subsequently given infusions of prostacyclin and nitroprusside. These drugs are potent vasodilators and prostacyclin also inhibits platelet aggregation. Recently it has been suggested that decreased prostacyclin production by the vessel wall endothelium plays a part in the development of Raynaud's syndrome and studies in adults have shown that intravenous prostacyclin reduces the frequency and duration of ischaemic attacks.20 In our patients prostacyclin and nitroprusside seemed to be helpful and one is now being successfully managed with a transdermal prostaglandin analogue. Antiplatelet treatment has also been advocated in Raynaud's syndrome as there is evidence that immunologically mediated endothelial damage and platelet activation contribute to the vascular disease.2' Patient 1 received standard antiplatelet treatment (salicylates and dipyridamole) but it is unclear how much this affected her recovery as she was also given a nitroprusside infusion when these medications were introduced. Two other vasodilators, nifedipine and ketanserin, were used in patient 5. The former is a calcium channel blocker and has been employed with varying degrees of success in adults with Raynaud's syndrome22 and the latter is a serotonin antagonist.23 Intravenous ketanserin was associated with considerable clinical improvement, but as the nifedipine was started while he was receiving ketanserin it is difficult to comment on the effect of this drug. From the experience with our patients, oral phenoxybenzamine seems to be useful for maintenance treatment of Raynaud's disease, and in the doses employed was not associated with any adverse side effects. In an acute attack we would suggest that infusions of prostacyclin, nitroprusside, or ketanserin be considered.
